Central serous chorioretinopathy in a patient with immune thrombocytopenic purpura
Abstract:

Immune thrombocytopenic purpura (ITP) is a disease characterized by low platelet count (<150,000/mm3). The suitable treatment for newly diagnosed ITP recommend longer courses of corticosteroids (eg, prednisone 1 mg/kg orally for 21 days then tapered off) or IVIg because longer courses of corticosteroids are associated with a longer time to the loss of response. We know that corticosteroids may cause side effects such as cataract, increased intraocular pressure and rarely central serous chorioretinopathy. This case report presents a patient with central serous chorioretinopathy after treatment for Immune thrombocytopenic purpura (ITP) that his visual outcome didn’t appropriate responses to our conventional therapy (corticosteroids stop). So we emphasize the thrombocytopenia could be the most responsible for CSCR in immune thrombocytopenic purpura patients.

Article Type:
Case Report
Language:
English
Published:
Journal of Case Reports in Practice, Volume:7 Issue:2, 2020
Pages:
11 - 13
magiran.com/p2083630  
روش‌های دسترسی به متن این مطلب
اشتراک شخصی
در سایت عضو شوید و هزینه اشتراک یک‌ساله سایت به مبلغ 300,000ريال را پرداخت کنید. همزمان با برقراری دوره اشتراک بسته دانلود 100 مطلب نیز برای شما فعال خواهد شد!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی همه کاربران به متن مطالب خریداری نمایند!